ClinicalTrials.Veeva

Menu

The PEACE (Posthumous Evaluation of Advanced Cancer Environment) Study

University College London (UCL) logo

University College London (UCL)

Status

Enrolling

Conditions

Solid Tumor, Adult
Cancer

Treatments

Other: Tissue Harvest

Study type

Observational

Funder types

Other

Identifiers

NCT03004755
UCL/13/0165

Details and patient eligibility

About

Historically, cancer research has been limited by sample acquisition in late stage disease, often restricted to single sites of disease with limited parallel clinical data collection in terms of prior therapy exposure. The PEACE study is intended to facilitate tissue donation from multiple tumour sites in the post-mortem setting and enable future research using samples collected at post-mortem within different disciplines related to cancer research.

Enrollment

500 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age 18 years or older
  • Confirmed diagnosis of any form of solid malignancy with metastatic disease (where the site of origin is known or unknown), with the exception of primary brain tumour in which there may not be evidence of metastatic disease
  • Oral and written informed consent from patient to enter the study and to undergo tumour harvesting after death or informed consent from a person in a qualifying relationship after the patient has died.

Exclusion criteria

  • Medical or psychiatric condition that would preclude informed consent
  • History of intravenous drug abuse within the last 5 years
  • History of known high-risk infections (e.g. HIV/AIDS-positive, hepatitis B/C, tuberculosis and Creutzfeldt-Jacob disease).

Trial contacts and locations

9

Loading...

Central trial contact

Abby Sharp

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems